HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Heron Therapeutics, Inc. (HRTX)
16.04  1.33  (9.04%) 07-02 01:12
Open: 14.85 High: 16.32
Pre.close: 14.71 Low: 14.8101
Volume: 3,383,932 Ave vol: 1,331,973
52w High: 26.81 52w Low: 9.6
MA(50): 18.22 MA(200): 18.18
EPS: -2.28 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.herontx.com
Market Cap (M): 1,454
Shares Out (M): 91
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron) extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy.
Technical analysis
Overall: Neutral
MA: Bearish MACD: Bearish
KDJ: Bearish RSI: Bullish
Target 1: 21.52 Target 2: 25.79
Resist 1: 18.43 Resist 2: 22.08
Support 1: 12.52 Support 2: 10.42
Company key metrics
Revenue per Share: 1.7853
Net Income per Share: -2.5037
Cash per Share: 0.8792
Book Value per Share: 4.9381
Price to Sales: 11.998
Price to Book Value: 4.3377
Earnings Yield: -0.1169
Dividend Yield: 0
Debt to Equity: 0.2698
Debt to Assets: 0.2125
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts
Headline news
Wed, 01 Jul 2020
Heron Therapeutics Inc. (HRTX) Soars 9.04% on July 01 - Equities.com

Mon, 29 Jun 2020
Implied Volatility Surging for Heron Therapeutics (HRTX) Stock Options - Yahoo Finance

Tue, 23 Jun 2020
Here is What Hedge Funds Think About Heron Therapeutics Inc (HRTX) - Yahoo Finance

Mon, 29 Jun 2020
Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain - Yahoo Finance

Sun, 28 Jun 2020
Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected To Breakeven - Simply Wall St

Wed, 01 Jul 2020
Heron Therapeutics Inc. (HRTX) Moves 3.19% Higher: These Numbers are Too Good to be True - News Daemon

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.